Navigation Links
Reportlinker Adds Clinical Trial Patient Recruitment: Accelerate Enrollment, Increase Retention and Reduce Costs
Date:9/14/2010

b>KEY METRICSThe five chapters in Clinical Trial Patient Recruitment include benchmarks that detail patient recruitment spending, structure, and activities, as well as data for patient enrollment motivators, recruitment tools and retention strategies.

Chapter 1: Supporting Patient Recruitment with Increased Budgets(52 data charts)

Patient recruitment budget data for sponsors, sites and CROs broken out by trial phase (Phase 1, 2, 3a and 3b, and 4):

• Percentage of clinical trial budget dedicated to patient recruitment

• Dedicated patient recruitment budgets (trials and sites)

• Total trial budgets per phase at trial level and site-specific level

• Patient recruitment budgets per patient enrolled

Patient recruitment spending data broken out by therapeutic area:

• Cardiovascular

• Central Nervous System/Neurology

• Type 2 Diabetes

• Hematology

• Infectious Disease

• Inflammation

• Mental Health

• Oncology

• Pain

• Urology

• Medical Device/Diagnostic?

Chapter 2: Integrating CRO Outsourcing with Internal Structure(5 data charts)

• Prominence of recruiting outsourcing, including reasons sponsors contract with vendors for patient recruitment

• Popularity of dedicated patient recruitment groups

• Efforts to integrate patient recruitment into trial protocol design

Chapter 3: Methods and Activities to Improve Patient Recruitment (31 data charts)

Data (including effectiveness rankings) for 16 patient recruitment activities:

• Evaluating site and investigators

• Conducting patient demographic/population research

• Working with advocacy groups

• Organizing health fairs and community outreach

• Training site staff/investigators on patient
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
2. Reportlinker Adds Global Coronary Stents Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
3. Reportlinker Adds Cardiovascular Surgery Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
4. Reportlinker Adds Respiratory Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
5. Reportlinker Adds Autistic Disorder - Pipeline Assessment and Market Forecasts to 2017
6. Reportlinker Adds Pharmaceutical Preparation Manufacturing Industry in the U.S. and Its International Trade [Q3 2010 Edition]
7. Reportlinker Adds US Enzymes Market
8. Reportlinker Adds Trends and Strategies in Pharmaceutical and Medical Device Branding
9. Reportlinker Adds Clinical Trials in China
10. Reportlinker Adds The Top 10 Orthopedic Device Companies: Financial performance, research activities, and growth strategies
11. Reportlinker Adds Cell Therapy - Technologies, Markets and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... Research and Markets( ... "Deciphering Global Major Pharmaceutical Companies, New Outsourcing ... It has been publicly recognized that ... a series of challenges in the recent years. ... overcapacities in small molecule product manufacturing; increasingly challenging ...
(Date:7/7/2015)... NEWTOWN, Pennsylvania , 7. Juli 2015 /PRNewswire/ ... Spezial-Dienstleistungen und -Technik für klinische Studien, gab heute ... (Medici) ein führendes Unternehmen bei Gewinnung und Erhalt ... umfasst die Tochtergesellschaften MediciGlobal , Ltd. und ... L2FU® auch einen Dienst zum Auffinden von ...
(Date:7/7/2015)... , July 7, 2015   InspireMD, Inc. ... a leader in embolic protection systems ("EPS"), today ... Protection System integrated with MicroNet ™ has ... Stent New Product Innovation Award.  Through active market ... analysts and consultants recognize the successful introduction of ...
Breaking Medicine Technology:Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 2Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 3BioClinica übernimmt MediciGroup 2BioClinica übernimmt MediciGroup 3BioClinica übernimmt MediciGroup 4InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 2InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 3InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 4InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 5
... NASHVILLE, Tenn., Aug. 4, 2011 Cumberland Pharmaceuticals Inc ... focused on hospital acute care and gastroenterology markets, today announced ...   For the three months ended June 30, 2011, net ... the prior year period. The growth in revenue was due ...
... Calif., Aug. 4, 2011 DURECT Corporation (Nasdaq: ... ended June 30, 2011. Total revenues increased to $7.8 million ... million for the three months ended June 30, 2010.  Net ... $5.2 million, compared to a net loss of $6.3 million ...
Cached Medicine Technology:Cumberland Pharmaceuticals Reports Second Quarter 2011 Financial Results 2Cumberland Pharmaceuticals Reports Second Quarter 2011 Financial Results 3Cumberland Pharmaceuticals Reports Second Quarter 2011 Financial Results 4Cumberland Pharmaceuticals Reports Second Quarter 2011 Financial Results 5Cumberland Pharmaceuticals Reports Second Quarter 2011 Financial Results 6Cumberland Pharmaceuticals Reports Second Quarter 2011 Financial Results 7Cumberland Pharmaceuticals Reports Second Quarter 2011 Financial Results 8Cumberland Pharmaceuticals Reports Second Quarter 2011 Financial Results 9Cumberland Pharmaceuticals Reports Second Quarter 2011 Financial Results 10Cumberland Pharmaceuticals Reports Second Quarter 2011 Financial Results 11Cumberland Pharmaceuticals Reports Second Quarter 2011 Financial Results 12DURECT Corporation Announces Second Quarter 2011 Financial Results and Update of Programs 2DURECT Corporation Announces Second Quarter 2011 Financial Results and Update of Programs 3DURECT Corporation Announces Second Quarter 2011 Financial Results and Update of Programs 4DURECT Corporation Announces Second Quarter 2011 Financial Results and Update of Programs 5DURECT Corporation Announces Second Quarter 2011 Financial Results and Update of Programs 6DURECT Corporation Announces Second Quarter 2011 Financial Results and Update of Programs 7DURECT Corporation Announces Second Quarter 2011 Financial Results and Update of Programs 8
(Date:7/7/2015)... ... ... Quadrino Law Group is pleased to announce the relocation of the firm's ... new facility is a state of the art building, located with easy access to ... and founder, said, "We are pleased to service our clients from such a premier ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... global provider of advanced delivery technologies and development solutions for drugs, biologics ... licensing agreement with Excelimmune, Inc. to access its antibody combination therapy (ACT) ...
(Date:7/7/2015)... ... , ... Summer is a great time to get outside and be active. ... safety tips. , Jean Tapley, senior wellness coordinator at Amica, suggests the following seven ... Start slowly. Going from no activity to several hours of activity can potentially ...
(Date:7/7/2015)... ... July 07, 2015 , ... On Saturday, May 16th, 2015, the ... Manistee Golf and Country Club. Best Drug Rehabilitation staff members were delighted to join ... underprivileged children. Kiwanis International, the parent of the Manistee Kiwanis Club, is a global ...
(Date:7/7/2015)... ... July 07, 2015 , ... FSAstore.com today announced the launch ... holders. HSAstore.com makes it simple to use, spend and manage HSA funds with innovative ... accounts. , According to a report by Devenir , approximately 13.8 million ...
Breaking Medicine News(10 mins):Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2Health News:Amica Insurance Has 7 Summer Safety Tips 2Health News:Best Drug Rehabilitation Team Participates in Kiwanis Club Golf Outing Fundraiser 2Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 2Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 3
... A chronic shortage of health workers in developing nations ... tuberculosis and malaria// , World Health Organization Director-General Margaret ... Health Day on April 7. ,Thousands of ... nations in search of higher paying jobs in wealthier ...
... and very poor, has banned the life-threatening practice of female ... ,Anybody involved in female genital mutilation (FGM) would be punished ... ,The move follows a campaign against the practice by the ... of Eritrean women are circumcised. ,'Female circumcision ...
... uncomfortable symptoms and help women feel better while going through ... in a woman's life when her menstrual cycle, associated with ... age 45. ,The four-month study by Penn ... 160 women, dividing them into three groups. ,One ...
... V’s Rabies monoclonal antibody (mAb) product has entered a ... launching// a similar study in the US. ... for the post-exposure prophylaxis of rabies, using Crucell’s MAbstract ... is closely linked to the initial phase I study ...
... Pharmaceuticals has treated the first patient in a new ... of Ceflatonin// (homoharringtonine or HHT) in patients with Chronic ... to treatment with two or more prior tyrosine kinase ... to complement the ongoing registration-directed clinical trial in CML ...
... New York City’s Department of Health and Mental Hygiene is ... AIDS to get circumcised in light of the World Health ... prevent the disease. ,In the United States, “New York ... R. Frieden, the city’s health commissioner, said in an interview. ...
Cached Medicine News:Health News:Eritrea Bans Female Circumcision 2Health News:Crucell's Rabies MAb Enters Phase I Trial in India 2Health News:New York City Plans to Promote Circumcision 2
... single liquid stable reagent offers the ... liquid stability to help maximize laboratory ... quick result turnaround time. The proprietary ... reagent provides a long shelf life ...
... powder reagent once reconstituted offers the ... liquid stability to help maximize laboratory ... quick result turnaround time. The proprietary ... reagent provides a long shelf life ...
LCD chart display...
Mobile offers full life cycle service for Sp02 accessories that are the vital link between pulse oximeter and patient...
Medicine Products: